[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ryan B. Corcoran<\/i><\/u><\/presenter>. Massachusetts General Hospital, Weston, MA","CSlideId":"","ControlKey":"56dd687e-7aeb-4ffc-b777-ed4f165f5270","ControlNumber":"104","DisclosureBlock":"&nbsp;<b>&nbsp;R.B. Corcoran:<\/b>  ; Alterome Therapeutics. ; Asana Biosciences. ; Avidity Biosciences. ; C4 Therapeutics. ; Cogent Biosciences. ; Eli Lilly and Company. ; Erasca. ; FOG pharma. ; Guardant Health. ; Interline Therapeutics. ; Kinnate Biopharma. ; Mirati Therapeutics. ; Nested Therapeutics. ; Novartis. ; Pfizer. ; Qiagen, LLC. ; Remix Therapeutics. ; Revolution Medicines. ; Taiho Pharmaceutical. ; Theonys. ; nRichDx.","End":"4\/17\/2023 12:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"102","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ryan Corcoran, MD;PhD","PresenterKey":"7449f103-e67f-4251-acda-d5bf87f198e5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ryan B. Corcoran<\/i><\/u><\/presenter>. Massachusetts General Hospital, Weston, MA","CSlideId":"","ControlKey":"3540a9d6-16c6-4671-b5e1-3414a6d4a63b","ControlNumber":"10343","DisclosureBlock":"<b>&nbsp;R. B. Corcoran, <\/b> <br><b>Alterome Therapeutics<\/b> I, S, I, S, I, S. <br><b>Asana Biosciences<\/b> I, I, I. <br><b>Avidity Biosciences<\/b> S, S, S. <br><b>C4 Therapeutics<\/b> I, S, I, S, I, S. <br><b>Cogent Biosciences<\/b> I, S, I, S, I, S. <br><b>Eli Lilly and Company<\/b> G, G, G. <br><b>Erasca<\/b> I, S, I, S, I, S. <br><b>FOG pharma<\/b> I, I, I. <br><b>Guardant Health<\/b> I, I, I. <br><b>Interline Therapeutics<\/b> I, S, I, S, I, S. <br><b>Kinnate Biopharma<\/b> I, S, I, S, I, S. <br><b>Mirati Therapeutics<\/b> I, I, I. <br><b>Nested Therapeutics<\/b> I, S, I, S, I, S. <br><b>Novartis<\/b> G, G, G. <br><b>Pfizer<\/b> I, G, I, G, I, G. <br><b>Qiagen, LLC<\/b> I, I, I. <br><b>Remix Therapeutics<\/b> I, S, I, S, I, S. <br><b>Revolution Medicines<\/b> I, S, I, S, I, S. <br><b>Taiho Pharmaceutical<\/b> I, I, I. <br><b>Theonys<\/b> I, S, I, S, I, S. <br><b>nRichDx<\/b> I, S, I, S, I, S.","End":"4\/17\/2023 12:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"9119","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ryan Corcoran, MD;PhD","PresenterKey":"7449f103-e67f-4251-acda-d5bf87f198e5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>James G. Christensen<\/i><\/u><\/presenter>. Mirati Therapeutics, San Diego, CA","CSlideId":"","ControlKey":"cddd5bcf-30a3-411c-b1dc-dd2615dba313","ControlNumber":"9260","DisclosureBlock":"","End":"4\/17\/2023 12:55:00 PM","HasWebcast":null,"Highlights":[],"Id":"2886","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"James Christensen, PhD","PresenterKey":"0f628e8e-f71d-48a4-b644-8a0b63f2a018","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Progress on development of KRAS allele-specific inhibitors and contribution of cell autonomous and pro-immunogenic activity to anti-tumor activity","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 12:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Progress on development of KRAS allele-specific inhibitors and contribution of cell autonomous and pro-immunogenic activity to anti-tumor activity","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"72562dae-8c1d-4038-9768-ccce8bdaa7b8","ControlNumber":"1876","DisclosureBlock":"","End":"4\/17\/2023 1:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"602","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 12:55:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Channing J. Der<\/i><\/u><\/presenter>. UNC Lineberger Comp. Cancer Center, Chapel Hill, NC","CSlideId":"","ControlKey":"020ccc35-5da7-43ba-9f8f-3bc8bd7d59fc","ControlNumber":"843","DisclosureBlock":"<b>&nbsp;C. J. Der, <\/b> <br><b>Mirati Therapeutics<\/b> I. <br><b>Revolution Medicines<\/b> G.","End":"4\/17\/2023 1:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"397","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Channing Der, PhD","PresenterKey":"1cc48153-2d5c-41ce-afa8-295f7fdaa7f0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Targeting KRAS for pancreatic cancer treatment","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 1:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Targeting KRAS for pancreatic cancer treatment","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"2760be04-0216-4223-9326-e3e39add210c","ControlNumber":"1877","DisclosureBlock":"","End":"4\/17\/2023 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"603","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 1:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ryan B. Corcoran<\/i><\/u><\/presenter>. Massachusetts General Hospital, Weston, MA","CSlideId":"","ControlKey":"a6d4c3df-d6ab-428c-b69b-ed7eaa937001","ControlNumber":"1327","DisclosureBlock":"<b>&nbsp;R. B. Corcoran, <\/b> <br><b>Alterome Therapeutics<\/b> I, S. <br><b>Asana Biosciences<\/b> I. <br><b>Avidity Biosciences<\/b> S. <br><b>C4 Therapeutics<\/b> I, S. <br><b>Cogent Biosciences<\/b> I, S. <br><b>Eli Lilly and Company<\/b> G. <br><b>Erasca<\/b> I, S. <br><b>FOG pharma<\/b> I. <br><b>Guardant Health<\/b> I. <br><b>Interline Therapeutics<\/b> I, S. <br><b>Kinnate Biopharma<\/b> I, S. <br><b>Mirati Therapeutics<\/b> I. <br><b>Nested Therapeutics<\/b> I, S. <br><b>Novartis<\/b> G. <br><b>Pfizer<\/b> I, G. <br><b>Qiagen, LLC<\/b> I. <br><b>Remix Therapeutics<\/b> I, S. <br><b>Revolution Medicines<\/b> I, S. <br><b>Taiho Pharmaceutical<\/b> I. <br><b>Theonys<\/b> I, S. <br><b>nRichDx<\/b> I, S.","End":"4\/17\/2023 1:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"471","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ryan Corcoran, MD;PhD","PresenterKey":"7449f103-e67f-4251-acda-d5bf87f198e5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Overcoming resistance to KRAS inhibition","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Overcoming resistance to KRAS inhibition","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"b17fa4e4-5188-4624-a9e9-737fe262dd6e","ControlNumber":"1878","DisclosureBlock":"","End":"4\/17\/2023 1:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"604","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 1:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"8544ee4b-bb47-415a-9e3c-e0296531b0b4","ControlNumber":"2065","DisclosureBlock":"","End":"4\/17\/2023 2:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"619","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"General Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023 12:30PM","SessionId":"75","SessionOnDemand":"False","SessionTitle":"Molecular Mechanisms of KRAS Pathway Inhibitors","ShowChatLink":"false","Start":"4\/17\/2023 1:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"General Discussion","Topics":null,"cSlideId":""}]